PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

I think your point goes to Item 6 on Mozz's list. However...

  1. 2,929 Posts.
    lightbulb Created with Sketch. 749
    I think your point goes to Item 6 on Mozz's list. However there only has to be evidence they can show safety and efficacy within the 6 years. The FDA are looking for support of claims and indications as well as relative benefits over existing treatments. That is a higher hurdle than efficacy IMO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.005(2.13%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.5¢ 24.0¢ 23.0¢ $63.43K 270.4K

Buyers (Bids)

No. Vol. Price($)
10 213534 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 76890 2
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.